Capital Investment Advisors’s Cardlytics CDLX Stock Holding History

Capital Investment Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-755	Closed	-$415K	–	565
2022 Q1	$415K	Hold	755	–	–	0.01%	394
2021 Q4	$499K	Hold	755	–	–	0.02%	375
2021 Q3	$634K	Hold	755	–	–	0.02%	334
2021 Q2	$958K	Hold	755	–	–	0.03%	278
2021 Q1	$828K	Hold	755	–	–	0.03%	285
2020 Q4	$1.08M	Hold	755	–	–	0.05%	231
2020 Q3	$533K	Hold	755	–	–	0.03%	308
2020 Q2	$528K	Hold	755	–	–	0.03%	304
2020 Q1	$264K	Hold	755	–	–	0.02%	368
2019 Q4	$475K	Hold	755	–	–	0.02%	327
2019 Q3	$253K	Buy	+755	New	+$242K	0.01%	423

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

JCM

JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital Investment Advisors's CDLX Position: Q2 2022 in Review

Capital Investment Advisors sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 755 shares — an estimated $415K sold.

Capital Investment Advisors first reported a position in CDLX in Q3 2019 and held it in 11 quarters. The position peaked at $1.08M in Q4 2020. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

Capital Investment Advisors reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
Capital Investment Advisors sold 755 Cardlytics shares in Q2 2022, an estimated $415K.
Capital Investment Advisors first reported a position in Cardlytics in Q3 2019 and held it in 11 quarters.
Capital Investment Advisors's Cardlytics position peaked at $1.08M in Q4 2020.
138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Capital Investment Advisors's 13F filing for Q2 2022, filed 6 Jul 2022.